Top 10 Risk Areas and Compliance Guidelines for R&D Expense Super Deduction
Deep analysis of 11 real-world audit cases
Tax "SkyNet" Is Online: Vertical Comparison, Cross-Department Verification, and Data Cross-Checks Leave No Room for Noncompliant R&D Expense Claims
In recent years, enhanced R&D expense super deductions have become a key tax lever for encouraging technological innovation. However, some companies treat this policy as "easy pickings," fraudulently claiming tax benefits by fabricating R&D projects, inflating R&D expenses, or listing fake R&D personnel.
With the deepening of "tax governance by data," tax authorities have established multi-dimensional data comparison models—analyzing historical fluctuations vertically, benchmarking against industry peers horizontally, and cross-verifying individual income tax, social security, and invoice data. This significantly narrows the room for non-compliant corporate practices.
The tax authority has made it clear: without genuine R&D activities, you cannot claim the additional deduction for R&D expenses.
Risks are primarily concentrated inQualification of R&D activities, accuracy of expense allocation, personnel hour distribution, and completeness of retained documentationFour core stages. Drawing on 11 real audit cases, we break down the ten most frequent risk points and compliance requirements one by one.
Qualification risks of R&D activities
Risk 1: Fictitious R&D projects or "pseudo-innovation"
Risk Indicators
Categorizing routine product upgrades and minor technical adjustments as "R&D projects"; using templated project proposals with a lack of innovative language; absence of milestone or final closure reports.
Compliance Key Points
R&D activities must have three key characteristics: innovation objectives, systematic organization, and unpredictable outcomes. The following seven types of activities do not qualify as R&D: routine product upgrades, direct application of existing technologies, market research, and others.
Typical Cases
[Case 1] Tianjin Huatong Aluminum Affiliated Company: Fabricated 12 projects
Tianjin Huatong Aluminum Co., Ltd. and Tianjin Huatong New Materials Co., Ltd. (controlled by the same legal representative) falsely declared 12 R&D projects to continue claiming super deduction tax benefits after ceasing actual R&D activities in 2021, during the period from 2020 to 2022. Investigators found that project proposals were templated, lacked professional language, and the company refused to provide R&D auxiliary ledgers while R&D personnel were consistently absent due to illness. The case was ultimately ruled as tax evasion, resulting in a total recovery of taxes, late fees, and penalties amounting to 13 million yuan.
[Case 2] Yongkai Construction Group: Repackaged "Industry-Academia-Research" Collaboration as Self-Developed Technology
Yongkai Construction Group Co., Ltd. falsely listed 18 R&D projects from 2018 to 2021. Investigation revealed that the company only signed a "Industry-Academia-Research Cooperation Agreement" with a certain university and purchased an invention patent, while its actual role was limited to "observing and monitoring data." No specific R&D activities were conducted, no R&D test records exist, and material consumption did not match the actual R&D content at all. As a result, the company was ordered to repay taxes, pay late fees, and incur fines totaling 631.66 million yuan.
Case 3: Jiashan Jingsheng Concrete – Repackaging Traditional Processes as "R&D"
The company claimed cumulative R&D expense super deductions totaling 607.19 million yuan from 2020 to 2022, yet reported no new patents after 2019. On-site inspection revealed the "R&D office" was cluttered with unused items. The alleged R&D merely involved adding commercially available water-reducing agents to existing concrete formulas—a trivial modification of current products. Additionally, unreported sales revenue of 316.88 million yuan was concealed. As a result, the company was ordered to repay taxes, pay late fees, and incur penalties totaling 609.14 million yuan.
[Case 4] Company A: Posing a Third-Party Product as In-House Developed
Company A fabricated project proposals, falsified material requisition records, and listed fake R&D personnel to disguise externally purchased mature products as self-developed ones, inflating R&D expenses by 472.13 ten thousand yuan. Tax authorities have recovered the tax due, levied late payment interest, and imposed corresponding fines. The lead regarding false invoicing has been transferred to public security organs for investigation.
Risk 2: Non-compliant benefits in restricted industries
Risk Indicators
Enterprises in the following six sectors may claim additional deductions: tobacco manufacturing, accommodation and dining, wholesale and retail, real estate, leasing and business services, and entertainment.
Compliance Key Points
Classify business segments based on whether industry revenue exceeds 50%. Proceed with caution.
Cost Collection and Accounting Risks
Risk 3: Incorrect allocation of personnel labor costs
Risk Indicators
Including administrative and sales staff salaries in R&D expenses; failing to allocate costs for non-full-time R&D personnel based on hours worked; misclassifying supplementary pension and medical insurance as personnel-related expenses (they should be categorized under "Other Related Expenses").
Compliance Key Points
Establish an R&D time ledger to allocate costs between R&D and production operations based on actual hours worked. Labor costs include only wages, social insurance, housing funds, and fees for outsourced R&D personnel.
Risk 4: "Other Related Expenses" exceeds the proportion or scope.
Risk Indicators
Include unlisted expenses such as communication fees and annual patent fees. Total other related expenses exceed 10% of the total R&D expenses eligible for additional deduction.
Compliance Key Points
Other related expenses follow a positive list and are limited to specific items such as technical book and material fees, expert consultation fees, travel expenses, and employee welfare benefits. The total must not exceed 10% of the total R&D expenses eligible for additional deduction.
Risk 5: Sales of R&D products were not offset against material costs.
Risk Indicators
Materials costs for products developed and sold during R&D activities were not deducted from R&D expenses.
Compliance Key Points
If product sales and material costs occur in different tax years, the deduction may be applied in the year of sale; any remaining amount can be carried forward to subsequent years.
Risk 6: Special revenue has not been offset by R&D expenses
Risk Indicators
Revenue from scrap, defective products, and intermediate trial items generated during R&D was not deducted from R&D expenses.
Compliance Key Points
Special income should be deducted from R&D expenses in a timely manner to ensure accurate expense allocation.
Typical Cases
Case 5: A company in Ningbo failed to deduct scrap income from R&D expenses.
A company in Ningbo generated a total of 22.7 yuan from waste disposal during R&D trials from 2020 to 2022. The proceeds were not deducted from R&D expenses as required, resulting in underpayment of taxes. Tax authorities audited the case and collected back taxes plus penalties.
Personnel and Manpower Management Risks
Risk 7: Researcher identity is questionable
Risk Indicators
Falsely listing R&D personnel; including individuals with no R&D background or actual R&D contributions in the scope of R&D expense allocation. Tax authorities can verify personnel authenticity by cross-referencing individual income tax and social security declaration data.
Compliance Key Points
Retain supporting documentation, including the list of R&D personnel, employment contracts, job descriptions, and academic/professional qualifications.
Risk 8: Lack of basis for labor allocation
Risk Indicators
Employees working on both R&D and non-R&D tasks have unstructured timesheet entries with no cross-verification.
Compliance Key Points
Time logs should align with attendance, project progress, and deliverables.
Typical Cases
Case 9: Executives "Named" on R&D Projects
A company included the wages of 62.5 ten thousand yuan and total expenses of 74.1 ten thousand yuan (including travel and social security) for its chairman and general manager—who did not actually participate in R&D—in R&D expenses. Investigation revealed that these two executives only provided "nominal guidance" and were not involved in the research project. These costs are not eligible for additional deduction.
Entity Eligibility and Filing Operation Risks
Risk 9: Invalid entity status
Risk Indicators
Non-compliant tax filings by enterprises under deemed assessment or non-resident enterprises; inadequate accounting systems and inability to accurately allocate R&D expenses.
Compliance Key Points
Available only to resident enterprises that maintain sound accounting practices, are subject to tax assessment based on accounts, and can accurately allocate R&D expenses.
Risk 10: Confusion in commissioned R&D roles
Risk Indicators
The entrusted party will claim its own additional deduction for R&D expenses commissioned. For domestic R&D commissions, the base amount is calculated at 100% instead of 80%.
Compliance Key Points
The trustee shall not apply additional deductions. For domestic R&D commissioned by the entrustor, the deduction base is calculated at 80% of the actual expenses incurred. Expenses for overseas R&D are deductible only up to the portion that does not exceed 2/3 of the qualified domestic R&D expenses.
Typical Cases
[Case 10] Shenzhen H Technology Company: Inflated R&D Expenses
Tech Company 2022 commissioned a related enterprise to develop software and declared R&D expenses of 1030 million yuan. Comparative review with similar companies revealed that material costs for software development should not exceed a small proportion, yet the contractor's declared material costs accounted for 70% of total expenses. Additionally, the commission price was significantly higher than the industry fair market value. After verification, the reasonable R&D expense should be 338 million yuan, meaning nearly 700 million yuan was over-declared. Following the adjustment of R&D expenses, the company no longer qualified for the "two-year tax exemption and three-year half-rate" incentive applicable to software enterprises, resulting in payment of back taxes and late fees totaling over 900 million yuan.
Critical Issue: Anomaly in Fee Structure Logic
Cost structure anomaly triggers verification
Risk Indicators
Tax authorities use big data analytics to monitor the reasonableness of expense structures. If additional deductions consist solely of personnel costs without corresponding material or depreciation expenses, or if any single expense category is disproportionately high, it may trigger an audit review.
Compliance Key Points
The expense date must not precede the project approval date to avoid the logical inconsistency of "expenditure before approval."
Typical Cases
Case 11: Shenzhen Jinsida — Falsely Listed Gold Material Consumption
Shenzhen Kingstar Application Materials Co., Ltd. falsely reported gold material expenses in its R&D costs, underpaying corporate income tax by 1621.16 million yuan. The company was later required to pay the owed taxes, late fees, and fines totaling 3618.15 million yuan.
Centralized Cases of Cost Allocation Issues
These three cases collectively highlight key issues in cost allocation (Risk 3-8).
Case 6: Xi'an Xinyu Modern CNC – Three Violations Combined
Between 2020 and 2023, the company inflated R&D expenses by: capitalizing over 300 million yuan in production materials as R&D costs (material share surged from 9% to over 50%), fully expensing depreciation for shared equipment without allocating it based on usage hours, and improperly classifying over 40 million yuan in business entertainment expenses under "Other Related Expenses." This resulted in an underpayment of corporate income tax totaling 108.75 million yuan. The company was subsequently required to pay back taxes, late fees, and a fine amounting to 211.14 million yuan.
Case 7: Zhejiang Chengkang Building Materials – Administrative Staff Impersonating R&D Personnel
The company claimed RMB 800 million in additional deductions for R&D expenses in year 2023, with the proportion of personnel costs in R&D spending surging from 28% to 40%. An investigation revealed that the company incorrectly included administrative staff salaries in its R&D deduction claims and fabricated R&D personnel records. As a result, it was ordered to pay back taxes, late fees, and penalties totaling RMB 115 million.
[Case 8] Shaanxi Yongming Coal Mine: Unauthorized Expansion of Personnel Scope
The company underpaid corporate income tax by 184.94 million yuan through irregularly expanding the scope of R&D personnel, fabricating R&D labor hours, and improperly including production and operating materials in R&D material expenses. Ultimately, it was required to pay back taxes, late fees, and fines totaling 323.41 million yuan.
Key Insight: How Big Data Leaves No Room for Violations
The above 11 cases reveal a common pattern: tax authorities have established risk screening models centered on tax big data.
Vertical comparison
Abnormal fluctuation in enterprise historical data: the proportion of R&D materials for Xi'an Xinyu increased sharply from 9% to over 50%.
Side-by-side comparison
Significant cost structure variations exist across the industry; for instance, H Tech's R&D materials account share far exceeds that of peers.
Cross-reference
Tax, social security, and invoice data cross-verify. For example, administrative staff salaries may conflict between tax filings and R&D expense allocations.
All non-compliant enterprises were exposed due to data anomalies.
Summary of Compliance Recommendations
Real occurrence is a prerequisite.
Do not fabricate projects or inflate expenses. Violations will result in tax repayment, late fees, and fines ranging from 0.5 to 5 times the amount. Criminal liability may be pursued if the offense constitutes a crime.
Accurate collection is key.
Distinguish between personnel costs and other related expenses, allocate labor hours accurately, and establish a supplementary ledger for R&D expenditures.
Complete information is essential.
Keep supporting documents for 10 years, including project initiation files, personnel allocation details, auxiliary accounts, and proof of results.
Enjoy all benefits, but proceed with caution.
Declining incentives may trigger tax authority inquiries into the authenticity of R&D expenses. We recommend claiming them in compliance whenever you qualify.
The only compliant path to enjoy discounts
Authentic R&D, Accurate Cost Allocation, Complete Documentation
In the era of data-driven tax governance, any侥幸心理 may come at a high cost.
Zhongshan Tax & Finance: Specialized in compliant data services for enterprise R&D projects
Help enterprises fully leverage tax benefits within a compliant framework.
Contact Now